These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7520579)

  • 21. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
    Carter HB; Morrell CH; Pearson JD; Brant LJ; Plato CC; Metter EJ; Chan DW; Fozard JL; Walsh PC
    Cancer Res; 1992 Jun; 52(12):3323-8. PubMed ID: 1375867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostate-specific antigen: contribution of monoclonal antibodies to its plasma determination by radioimmunoassay].
    Gutiérrez Mínguez E; García Talavera JR; Martín Rodríguez M; Sánchez González ML; Díaz Alférez FJ; Urrutia Avisrror M
    Arch Esp Urol; 1988 Apr; 41(3):188-92. PubMed ID: 2456746
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of prostate-specific antigen in urologic pathology. Preliminary results].
    Morote Robles J; Genollar Subirats J
    Arch Esp Urol; 1985; 38(6):562-6. PubMed ID: 2421651
    [No Abstract]   [Full Text] [Related]  

  • 26. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
    Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
    Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.
    Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ
    Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological basis for elevation of serum prostate specific antigen].
    Xia TL; Deng FM; Feng T
    Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):306-8, 327. PubMed ID: 7525028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer.
    Armitage TG; Cooper EH; Newling DW; Robinson MR; Appleyard I
    Br J Urol; 1988 Dec; 62(6):584-9. PubMed ID: 2464397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate-specific antigen. A new marker of prostatic pathology].
    Boccon-Gibod L; Géraud M; Dugué MA
    Ann Urol (Paris); 1988; 22(3):206-10. PubMed ID: 2456714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario.
    Glenski WJ; Malek RS; Myrtle JF; Oesterling JE
    Mayo Clin Proc; 1992 Mar; 67(3):249-52. PubMed ID: 1372057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiprostasome antibody titres in benign and malignant prostate disease.
    Minelli A; Ronquist G; Carlsson L; Mearini E; Nilsson O; Larsson A
    Anticancer Res; 2005; 25(6C):4399-402. PubMed ID: 16334115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Bentvelsen FM; Bogdanowicz JF; Oosterom R; Schröder FH
    Ned Tijdschr Geneeskd; 1990 Aug; 134(33):1596-600. PubMed ID: 1697651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.
    Rock RC; Chan DW; Bruzek D; Waldron C; Oesterling J; Walsh P
    Clin Chem; 1987 Dec; 33(12):2257-61. PubMed ID: 2446807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural-killer-cell-associated HNK-1 (Leu-7) antibody reacts with hypertrophic and malignant prostatic epithelium.
    Rusthoven JJ; Robinson JB; Kolin A; Pinkerton PH
    Cancer; 1985 Jul; 56(2):289-93. PubMed ID: 2408730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medically significant concentrations of prostate-specific antigen in serum assessed.
    Bernstein LH; Rudolph RA; Pinto MM; Viner N; Zuckerman H
    Clin Chem; 1990 Mar; 36(3):515-8. PubMed ID: 1690092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of prostate specific antigen in prostatic cancer.
    Guinan P; Bhatti R; Ray P
    J Urol; 1987 Apr; 137(4):686-9. PubMed ID: 2435927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.